logo
Beloved toy company founder who helped millions of kids learn to read dies by assisted suicide, leaving legacy of literacy; who is he and why did he take this step?

Beloved toy company founder who helped millions of kids learn to read dies by assisted suicide, leaving legacy of literacy; who is he and why did he take this step?

Time of India23-04-2025
Mike Wood
, founder of
LeapFrog Enterprises
, the firm that revolutionized how children learn to read, has died by physician
assisted suicide
at the age of 72, as per a report. Wood died on April 10 in
Dignitas
, a nonprofit assisted dying center in Zurich, Switzerland, in the presence of family members, The New York Times reported.
Why Mike Wood Chose Physician-Assisted Suicide
His brother, Tim shared that Wood was suffering from
Alzheimer's
and so he had decided to end his life before the disease could progress too far, according to the report.
Switzerland permits assisted dying, but only if the person who's making the request is of sound mind and not driven by selfish reasons, like for money, according to Daily Mail. Clinics like Dignitas, the country's most famous clinic where hundreds of people have died in the past 20 years, has strict rules that its clients must be terminally ill, suffering extreme pain or living with an 'unendurable disability', reported Daily Mail.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
When Every Gram Matters
Trek Kit India
Buy Now
Undo
LeapFrog's Success and Growth
A pioneer of children's learning, Wood's innovation has reached millions of homes, infinite classrooms, and a whole generation of readers. His foray into this industry wasn't an intentional career choice, but it was his experience as a dad, worrying for his young son, that led him to create this global toy company, as per Daily Mail.
When Wood noticed that his then three-year-old son, Mat, knew the alphabet but could not pronounce the letter sounds, he was concerned that if his child lagged as a reader, he would forever struggle, as per the report. His concern about his son's learning, led him to make a prototype of an electronic toy that played sounds when children squeezed plastic letters and then he developed the
Phonics Desk
in 1995, according to Daily Mail.
Live Events
LeapFrog's success attracted investors such as Michael Milken and Oracle founder Larry Ellison, as per the report. In 1997, their education firm, Knowledge Universe, acquired a majority stake in LeapFrog for millions of dollars, investing in product development, reported Daily Mail. With this capital, Wood bought a company that assisted in developing the LeapPad, which he demanded be no more than $49 for Toys R Us customers, according to the report.
Wood's Continued Impact On Children
Even though the company was very successful, Wood had decided to step down from his position in the toy company in 2004 at the age of 51, as per Daily Mail. Wood then, founded and sold another reading education company,
Smarty Ants
, an online learning program, as per the report. Recently, he had volunteered as a reading teacher at a school near his home, where more than half of the students are classified by the state of California as socioeconomically disadvantaged, reported Daily Mail.
FAQs
Where did Mike Wood die?
Wood died at Dignitas, a nonprofit assisted dying clinic in Zurich, Switzerland, as per a report.
Why did Mike Wood choose to end his life?
Wood chose to end his life before his Alzheimer's progressed further.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Indian scientists explore potential cure for Alzheimer's Disease using microRNAs
Indian scientists explore potential cure for Alzheimer's Disease using microRNAs

Hans India

time3 hours ago

  • Hans India

Indian scientists explore potential cure for Alzheimer's Disease using microRNAs

MicroRNAs (miRNAs) - the discovery of which received the Nobel Prize in Physiology or Medicine last year - may play a significant role in the treatment and cure of Alzheimer's Disease (AD), said researchers from Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR). Alzheimer's Disease is a devastating condition that steals away mental faculties and debilitates day-to-day life of patients. Characterised by the accumulation of protein clumps in the brain, memory loss, and cognitive deficits, it is estimated to affect more than 57.4 million people worldwide, a number that is expected to almost triple to 152.8 million cases by 2050. Addressing this, researchers from JNCASR, an autonomous institute of the Department of Science and Technology (DST), explored altered miRNAs in the Alzheimer's brain for early, specific, and accurate clinical diagnosis of the condition. The study published in the journal NAR Molecular Medicine 'unveiled various miRNA-mRNA pathway networks altered in Alzheimer's, which could potentially reveal various pathways to target for drug development,' said the team led by Madhu Ramesh and Prof. Thimmaiah Govindaraju from JNCASR. In the study, the researchers used a double transgenic AD mouse model to discover novel miRNAs involved in AD development and progression and identified various miRNAs that are altered in the AD brain compared to the normal brain, which could potentially trigger the disease. They discovered a significant increase in miR-7a -- which targets the protein Klf4 -- a master regulator of various gene expressions involved in Alzheimer's. Their detailed study showed that the miR-7a-Klf4 axis regulates neuroinflammation -- a major cause of Alzheimer's pathology. This axis also regulates an iron-mediated neuronal cell death mechanism involved in Alzheimer's called ferroptosis. 'The study offers valuable insight into Alzheimer's disease by uncovering the regulatory role of miR-7a in controlling neuroinflammation and ferroptosis via Klf4 targeting,' said Govindaraju. The researchers also developed a miRNA-based therapeutic that targets Klf4 to prevent neuroinflammation and ferroptosis. They carefully modified miR-7a to synthesise a mimic that significantly silenced Klf4 levels and rescued disease pathologies. They used Honokiol -- a small molecule and natural product for pharmacological modulation of the miR7a-Klf4 axis. Honokiol is a natural product found in bark and seed cones of Magnolia tree that targets Klf4 to stall neuroinflammation and ferroptotic cell death involved in Alzheimer's. This demonstrates that the miR-7a-Klf4 axis is a novel target for Alzheimer's and warrants further exploration to develop better therapeutics for the disease, the team said. 'With clinical evaluation, the developed miRNA mimic and small molecule, if proven safe and effective, could potentially cure Alzheimer's, benefiting both patients and caregivers,' they noted.

Harvard study finds certain jobs could lower Alzheimer's Risk- Here's why
Harvard study finds certain jobs could lower Alzheimer's Risk- Here's why

Time of India

time15 hours ago

  • Time of India

Harvard study finds certain jobs could lower Alzheimer's Risk- Here's why

A new report from Harvard Health Publishing has found an interesting connection between some jobs and a lower risk of dying from Alzheimer's disease. Taxi and ambulance drivers, surprisingly, had the lowest rates of death from Alzheimer's disease. Experts think that the constant mental demands of these jobs may help keep the brain sharper for longer, as per a report by TOI. How does navigation protect the brain? Harvard Health Publishing says that some jobs may be good for brain health in ways you didn't expect, especially when it comes to Alzheimer's disease. Dr. Robert H. Shmerling looked at some research and found that taxi and ambulance drivers had a lot fewer deaths related to Alzheimer's than people in a lot of other jobs. Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program ALSO READ: Donald Trump to host Kennedy Center honors — see the surprising list of this year's recipients One possibility is that these jobs keep your mind busy all the time. Drivers have to remember routes, plan trips on the fly, deal with changing traffic, and make quick decisions when they are under pressure. Researchers believe that this level of mental activity strengthens the hippocampus, as per a report by TOI. This is the part of the brain that controls memory and spatial awareness. Alzheimer's disease affects this area first. Live Events There have been studies before, like one on London taxi drivers, that show this part of the brain can get bigger when it has to deal with navigation problems over and over again. This "mental mapping" could help your brain stay sharp over time, which is something that Alzheimer's usually prevents, as per a report by TOI. Why aren't all jobs that require travel just as good? You might think that bus drivers, ship captains, and pilots would all want the same kind of brain protection, but the data shows that this isn't true. The study found that pilots and ship captains had some of the highest rates of death from Alzheimer's disease, at 2.34% and 2.12%, respectively, as per a report by TOI. The rate for taxi drivers was 0.91%, and the rate for ambulance drivers was 1.03%. This is much lower than the rate for chief executives, which was 1.82%. Experts say the difference is in how much people are working to solve problems. Pilots often get help from air traffic control and autopilot. Ship captains and bus drivers usually follow the same routes every day. Taxi and ambulance drivers, on the other hand, are always changing their destinations, dealing with problems that come up out of nowhere, and racing against the clock. This makes their jobs harder mentally, which could help keep their brains healthy. Can doing things every day help your brain the same way? Researchers believe that some of the brain-boosting effects can be used in daily life, even though most people don't drive taxis or ambulances for a living. It might be good for you to do hobbies that make you think about space and how to deal with new situations. Some examples are hiking in places you don't know, orienteering, geocaching, and using a map and compass, as per a report by TOI. The hippocampus may stay active by doing things like solving difficult jigsaw puzzles, working on a Rubik's Cube, or playing video games that require a lot of spatial thinking, like Tetris or Minecraft. Scientists say that these things are good for your brain, but they don't have enough proof to say that they lower the risk of Alzheimer's in the same way that professional driving does. What do you need to know about stopping Alzheimer's? This study doesn't show that driving a taxi or ambulance will keep you from getting Alzheimer's, but it does make a stronger case for keeping your brain busy. Harvard experts say that the best way to keep your brain healthy and safe from Alzheimer's and other types of dementia is to do mentally challenging things along with other things that are known to work, like getting enough sleep, eating a balanced diet, working out regularly, and having strong social ties, as per a report by TOI. FAQs Which jobs may reduce Alzheimer's risk? Taxi and ambulance driving jobs had significantly lower Alzheimer's-related death rates. How could these jobs protect the brain? Constant navigation and decision-making may help the hippocampus remain healthy.

Women with Down Syndrome Show Faster Alzheimer's Progression Than Men, Study Finds
Women with Down Syndrome Show Faster Alzheimer's Progression Than Men, Study Finds

India.com

time17 hours ago

  • India.com

Women with Down Syndrome Show Faster Alzheimer's Progression Than Men, Study Finds

New Delhi: Women with Down syndrome have more advanced signs of Alzheimer's disease than men do, according to research. However, the average age of Down syndrome diagnosis is the same for both men and women, said the University of California, Irvine. The study suggests that women with Down syndrome may carry a higher burden of beta amyloid and phosphorylated tau -- two hallmark Alzheimer's proteins -- than men. It was particularly high in the occipital lobe in women with sporadic Alzheimer's disease -- the more common, late-onset form of Alzheimer's that occurs without a clear genetic cause. This insight points to the need for more sex-specific approaches in both Alzheimer's research and treatment planning, especially in the design of clinical trials. Women versus men "Understanding selective vulnerabilities within the brain and how these differ in women versus men will help us to better navigate treatment outcomes. We're learning the importance of modifiable risk factors, which include accounting for sex-specific risk," said lead author Elizabeth Andrews, doctoral candidate at the varsity. Alzheimer's disease is the primary cause of death for individuals with Down syndrome, who are genetically predisposed to develop the condition earlier in life. While previous studies observed that women with Down syndrome may live longer with dementia than men with Down syndrome, few have looked closely at whether the underlying brain pathology differs by sex. Researchers examined postmortem brain samples In this study, the researchers examined postmortem brain samples and measured levels of beta amyloid and tau. The findings, published in the journal Alzheimer's & Dementia, can shape how we understand and approach treatments for Alzheimer's in this population and beyond. "If women with Down syndrome are further along in disease progression at the time of diagnosis, it could change how we time interventions and interpret outcomes in clinical trials," said Elizabeth Head, Professor of pathology at UC Irvine. "This research could help tailor therapies more effectively, not just for people with Down syndrome, but for the broader Alzheimer's population as well," Head added.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store